Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted cervical cancer vaccine in healthy Indian women

• BHATLA Neerja

  All India Institute of Medical Sciences

• SURI Vanita

  Postgraduate Institute of Medical Education and Research

• BASU Partha

  Chittaranjan National Career Institute

• SHASTRI Surendra

  Tata Memorial Cancer Hospital

• DATTA Sanjoy K.

  GlaxoSmithKline Biologicals

• BI Dan

  GlaxoSmithKline Biologicals

• DESCAMPS Dominique J.

  GlaxoSmithKline Biologicals

• BOCK Hans L.

  GlaxoSmithKline Biologicals

• DAS Amit

  Chittarnajan National Cancer Institute

• GULATI Arti

  All India Institute of Medical Sciences

• JOSEPH Elizabeth

  All India Institute of Medical Sciences

• LAL Neena

  All India Institute of Medical Sciences

• MANDAL Ranajit

  Chittaranjan National Cancer Institute

• NIJHAWAN Raje

  Post Graduate Institute of Medical Education and Research

• PIMPLE Sharmila

  Tata Memorial Hospital

収録刊行物

• The journal of obstetrics and gynaecology research

  The journal of obstetrics and gynaecology research 36 (1), 123-132, 2010-02-01

キーワード

• AS04-adjuvanted
• cervical cancer
• HPV-16
• HPV-18
• immunogenicity
• seroconverted

詳細情報

• CRID: 1573950400910222976
• NII論文ID: 10031121584
• NII書誌ID: AA11082002
• ISSN: 13418076
• Web Site: https://search.jamas.or.jp/link/ui/2010281749
• 本文言語コード: en
• データソース種別:
  • CiNii Articles